Chevallard Daniel R.

EDGAR CIK 0001706176

LENZ Therapeutics, Inc. - LENZ

  1. Manufacturing
  2. Chemicals
  3. Biological Products, (no Disgnostic Substances)
CFO
Chief Financial Officer
Direct Buys
2
$114,292
9,698 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
03/27/2026
03/30/2026
Buy
7,500 @ $8.57
 $64,275 12,886 (139.25%) Direct
11/07/2025
11/07/2025
Buy
2,198 @ $22.76
 $50,017 5,386 (68.95%) Direct